These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22102891)
1. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. Chougule MB; Patel A; Sachdeva P; Jackson T; Singh M PLoS One; 2011; 6(11):e27394. PubMed ID: 22102891 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model. Jackson T; Chougule MB; Ichite N; Patlolla RR; Singh M Cancer Chemother Pharmacol; 2008 Dec; 63(1):117-26. PubMed ID: 18338172 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. Chougule MB; Patel AR; Jackson T; Singh M PLoS One; 2011 Mar; 6(3):e17733. PubMed ID: 21423660 [TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Chougule M; Patel AR; Sachdeva P; Jackson T; Singh M Lung Cancer; 2011 Mar; 71(3):271-82. PubMed ID: 20674069 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model. Zhou S; Yang Y; Yang Y; Tao H; Li D; Zhang J; Jiang G; Fang J PLoS One; 2013; 8(7):e68589. PubMed ID: 23874680 [TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine. Bocci G; Danesi R; Marangoni G; Fioravanti A; Boggi U; Esposito I; Fasciani A; Boschi E; Campani D; Bevilacqua G; Mosca F; Del Tacca M Eur J Pharmacol; 2004 Sep; 498(1-3):9-18. PubMed ID: 15363970 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy. Casneuf VF; Demetter P; Boterberg T; Delrue L; Peeters M; Van Damme N Oncol Rep; 2009 Jul; 22(1):105-13. PubMed ID: 19513511 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer. Awasthi N; Zhang C; Ruan W; Schwarz MA; Schwarz RE PLoS One; 2012; 7(6):e38477. PubMed ID: 22723862 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo]. Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823 [TBL] [Abstract][Full Text] [Related]
11. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma. Feng F; Wang B; Sun X; Zhu Y; Tang H; Nan G; Wang L; Wu B; Huhe M; Liu S; Diao T; Hou R; Zhang Y; Zhang Z Cancer Biol Ther; 2017 Jan; 18(1):51-62. PubMed ID: 28055291 [TBL] [Abstract][Full Text] [Related]
12. Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative. Zhang Y; Zhang H; Chen J; Zhao H; Zeng X; Zhang H; Qing C Invest New Drugs; 2012 Feb; 30(1):8-16. PubMed ID: 20711631 [TBL] [Abstract][Full Text] [Related]
13. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Zhang R; Ru Y; Gao Y; Li J; Mao S Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713 [TBL] [Abstract][Full Text] [Related]
14. EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer. Schwarz RE; Awasthi N; Konduri S; Cafasso D; Schwarz MA Ann Surg Oncol; 2010 May; 17(5):1442-52. PubMed ID: 20041350 [TBL] [Abstract][Full Text] [Related]
15. Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cells. Tokunaga Y; Liu D; Nakano J; Zhang X; Nii K; Go T; Huang CL; Yokomise H Eur J Cancer; 2015 Nov; 51(16):2480-9. PubMed ID: 26254808 [TBL] [Abstract][Full Text] [Related]
16. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
17. Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile. Giovannetti E; Mey V; Danesi R; Basolo F; Barachini S; Deri M; Del Tacca M Br J Cancer; 2005 Feb; 92(4):681-9. PubMed ID: 15700043 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of hyperthermia and Gemcitabine in lung cancer. Vertrees RA; Das GC; Popov VL; Coscio AM; Goodwin TJ; Logrono R; Zwischenberger JB; Boor PJ Cancer Biol Ther; 2005 Oct; 4(10):1144-53. PubMed ID: 16138007 [TBL] [Abstract][Full Text] [Related]
19. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing. Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051 [TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]